NCT05963932View on ClinicalTrials.gov

A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 8, 2023

Primary Completion Date

October 17, 2023

Study Completion Date

October 17, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

BMS-986419 DR Capsule

Specified dose on specified days

DRUG

BMS-986419 IR Tablet

Specified dose on specified days

Trial Locations (1)

92801

Anaheim Clinical Trials, Anaheim

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05963932 - A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult Participants | Biotech Hunter | Biotech Hunter